Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Abbott releases new...

    Abbott releases new round of cyber updates for St. Jude pacemakers

    Written by Ruby Khatun Khatun Published On 2017-09-03T13:37:25+05:30  |  Updated On 3 Sept 2017 1:37 PM IST
    Abbott releases new round of cyber updates for St. Jude pacemakers

    NEW YORK: Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude heart implants being hacked and to warn patients that the devices’ batteries may run down earlier than expected.


    It was the second round of updates for the heart implants that Abbott has announced since buying medical device maker St. Jude Medical earlier this year.


    The U.S. government launched a probe last year of claims the devices were vulnerable to potentially life-threatening hacks that could cause implanted devices to pace at potentially dangerous rates or cause them to fail by draining their batteries.


    The company also identified a separate problem with lithium batteries in its heart devices last year. St. Jude recalled some of its 400,000 implanted heart devices last October due to the risk of premature battery depletion, which was linked to two deaths in Europe.


    The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned patients with an already implanted device to seek immediate medical attention if they get a low-battery alert.


    “Abbott is resolving all old St. Jude Medical issues,” Abbott spokeswoman Candace Steele Flippin said.


    The new update will provide doctors with an earlier warning when the batteries in Abbott’s implantable cardioverter defibrillators are at risk of early depletion.


    Abbott said it would also update the software embedded in pacemakers to reduce the risk of hacking. The company said there have been no reports of unauthorized access to any patient’s implanted device and that compromising the security of the devices would require a complex set of circumstances.


    The FDA said it approved the update to ensure that it addresses the cyber security vulnerabilities, and reduces the risk of patient harm.


    The FDA and the Department of Homeland Security confirmed in January that St. Jude devices were vulnerable to hacking. But they said they knew of no cyber attacks on patients with the company’s cardiac implants.


    The FDA said the benefits of continuing treatment outweighed cyber risks, and DHS said only an attacker “with high skill” could exploit the vulnerability.


    They launched the probe in August after short-selling firm Muddy Waters and cyber security firm MedSec Holdings said the devices were riddled with security flaws that made them vulnerable to potentially life-threatening hacks.


    When Muddy Waters went public with the claims, it also disclosed it was shorting shares of St. Jude Medical, which was preparing to sell itself to Abbott. The short-selling firm said it believed that disclosure of the vulnerabilities could cause the $25 billion deal to fall apart, but Abbot completed the deal in January.




    (Reporting by Michael Erman; Editing by Dan Grebler and Richard Chang)



    Abbottcyber updatesFDAheart implantslithium batteriesmedical devicenew roundpacemakerspremature battery depletionreleasesriskSt JudeSteele FlippinU.S. Food and Drug Administration
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok